Saye Khoo
MD, PhD
Royal Liverpool University Hospital; University of Liverpool, United Kingdom
The 7th edition of The Liverpool Course 2025 will take place in the morning of 3 September 2025, before the 26th International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2025 kicks off.
Designed and developed by renowned experts in the field of HIV care and pharmacology, The Liverpool Course aims to educate participants on key concepts in clinical pharmacology and drug-drug interactions that remain a major consideration in the management of people living with HIV.
The course is organized in collaboration with the University of Liverpool and the leading experts who developed the Liverpool HIV drug interactions checker - a comprehensive drug-drug-interaction resource freely available to healthcare practitioners worldwide.
MD, PhD
Royal Liverpool University Hospital; University of Liverpool, United Kingdom
FRPharmS
University of Liverpool, United Kingdom
PharmD, PhD
University Hospital of Basel, University Hospital of Lausanne, Switzerland; University of Liverpool, United Kingdom
MD
National Hemophilia Center, Sheba Medical Center, Israel
B.Sc.Phm., PharmD, FCSHP, AAHIVP
Toronto General Hospital, University of Toronto, Canada
jesper.niesen@amededu.com